Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02483910 · ClinicalTrials.gov registry record · NA
Direct Instruction Language for Learning in Autism Spectrum Disorder
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 137
- Enrollment target
NCT02483910 is a NA study that has completed, run by Emory University. The registered enrollment target is 137 participants.
The verdict
NCT02483910, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 137 participants
- Enrollment target
Study Summary
The purpose of this study is to test whether Direct Instruction - Language for Learning (DI-LL) is an effective way to teach language skills to children with autism spectrum disorder (ASD) and moderate language delay. Direct Instruction - Language for Learning (DI-LL) uses face to face instruction and specific lessons to teach children language skills. This method has been used previously in children with language delays, but it has not been carefully studied in children with autism spectrum disorder. This study will compare DI-LL and ongoing treatment as usual to treatment as usual (speech therapy, language services, etc.) alone.
Interventions
- BEHAVIORAL Direct Instruction-Language for Learning (DI-LL) via telehealth (e.g., Zoom or WebEx)
- BEHAVIORAL Standard of care delivered via telehealth (e.g., Zoom or WebEx)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 137 participants |
| Start Date | 2015-10 |
| Est. Completion | 2020-11-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02483910
The ClinicalTrials.gov registry entry for NCT02483910 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 137 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Direct Instruction-Language for Learning (DI-LL) via telehealth (e.g., Zoom or WebEx) is the first listed.
NCT02483910 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02483910 about?
NCT02483910 is a clinical study titled "Direct Instruction Language for Learning in Autism Spectrum Disorder". The purpose of this study is to test whether Direct Instruction - Language for Learning (DI-LL) is an effective way to teach language skills to children with autism spectrum disorder (ASD) and moderate language delay. Direct Instruction - Language for Learning (DI-LL) uses face to face instruction a...
What is the current status of trial NCT02483910?
This trial is currently completed. It is a NA study. The enrollment target is 137 participants. The study started on 2015-10. Estimated completion is 2020-11-24.
What interventions are being tested in trial NCT02483910?
The interventions under investigation include: Direct Instruction-Language for Learning (DI-LL) via telehealth (e.g., Zoom or WebEx) (BEHAVIORAL), Standard of care delivered via telehealth (e.g., Zoom or WebEx) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02483910?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.